Trusted Resources: People & Places
Online groups, photo galleries and blogs
CHOP – Lysosomal Storage Disease (LSD) Center
3401 Civic Center Blvd.Philadelphia, Pennsylvania, United States
Phone Web
The Lysosomal Storage Disease Center at Children’s Hospital of Philadelphia (CHOP) provides comprehensive testing, treatment and management for children, adolescents and young adults with a diagnosis or suspected diagnosis of lysosomal storage diseases (LSD) like Mucopolysaccharidosis.
Treatment for LSDs includes enzyme replacement therapy and bone marrow transplants to maximize patient outcomes. At CHOP’s LSD Center, we work with families to coordinate services across a therapeutic team.
Why Choose Us?
The Lysosomal Storage Disease Center combines excellent clinical care with access to active clinical research and new drug trials for patients interested in participating. Our team has been involved in LSD diagnosis and management for more than 20 years and has been recognized as a center for excellence. Our multidisciplinary clinics are devoted to our patients and aim to improve patient outcomes and satisfaction.
Conditions We Treat:
• Mucopolysaccharidosis Type 1
• Mucopolysaccharidosis Type II
Related Content
-
The Surgical Management of Spinal Disorders in Lysosomal Storage Diseases: A Systematic ReviewThe skeletal manifestations of lysosomal...
-
Golgi Requires a New Casting in the Screenplay of Mucopolysaccharidosis II CytopathologyLysosome (L), a hydrolytic compartment o...
-
AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysacc...AVROBIO, Inc., a leading clinical-stage ...
-
Newborn Screening of Mucopolysaccharidosis Type IMucopolysaccharidosis type I (MPS I), a ...
-
Burden of Morbidity After Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A BMT Survivor...Survival after blood or marrow transplan...
-
New Type A ERT Candidate on Track for Clinical TrialJapanese company, JCR Pharmaceuticals, h...
-
Hurler Holes in Hunter SyndromeA 16-year-old male presented to our hosp...